Featuring: Emily Rash (COO) and Dr. Neil Gheewala (CMO of Value-Based Care), US Heart and Vascular
—
Is 3-6 weeks really how long patients should have to wait to see a cardiologist?
That’s the national average — and it’s the exact inefficiency Emily Rash (COO) and Dr. Neil Gheewala (CMO of Value-Based Care) at US Heart and Vascular are betting they can fix. Blake Madden sat down with them for a refreshingly candid conversation about what actually separates an integrated cardiology platform from a bunch of practices bolted onto a cap table.
In this episode:
- The Ares + Rubicon Founders dual capital structure — arguably the sharpest specialty-VBC sponsor pairing out there
- The “AIR” framework (autonomy, independence, representative governance), and why the third leg is the one most rollups get wrong
- Why cardiology might be the cleanest specialty fit for value-based care, full stop (no structural fee-for-service conflict the way a hospital has)
- Neil’s actual pitch to RFK Jr. for a “Level 6” reimbursement category for ambulatory IV diuretics (CMMI, this one’s free)
- Where cardiology bifurcates in the next five years: outpatient access groups vs. hospital-based acute care
If specialty VBC, physician governance, or the cardiology rollup wave are anywhere on your radar, this one’s worth the listen.
—
Navvis partners with health systems and health plans to deliver real performance improvement across value-based care and fee-for-service models.
https://navvishealthcare.com/vbc
—
For expert analysis on healthcare M&A, strategy, finance, and markets, join 68K+ readers of Blake Madden’s Hospitalogy newsletter. Subscribe here: https://hospitalogy.com/
Like our podcast? Listen to previous episodes here: https://hospitalogy.com/podcast/
Be sure to leave us a review, and share our podcast with colleagues.
Follow Blake Madden on LinkedIn: https://www.linkedin.com/in/blakecmadden/